These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22212394)

  • 41. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein.
    Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refolding of recombinant human granulocyte colony stimulating factor: effect of cysteine/cystine redox system.
    Tiwari K; Shebannavar S; Kattavarapu K; Pokalwar S; Mishra MK; Chauhan UK
    Indian J Biochem Biophys; 2012 Aug; 49(4):285-8. PubMed ID: 23077791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Optimization of induction and purification of HIV-1 Gag protein in Escherichia coli expression system].
    Fu J; Sun J; Chen P; Huo Z; Hao Y; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1306-11. PubMed ID: 18837413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
    Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
    Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
    Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
    Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Renaturation with simultaneous purification of the recombinant human Flt3 ligand from inclusion bodies by high performance hydrophobic interaction chromatography].
    Jia J; Wang L; Gao D; Geng X
    Se Pu; 2010 Jun; 28(6):535-40. PubMed ID: 20873571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Advances in in vitro refolding of inclusion body proteins].
    Fang M; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and its derivative ND 28 with polyethylene glycol.
    Yamasaki M; Asano M; Okabe M; Morimoto M; Yokoo Y
    J Biochem; 1994 May; 115(5):814-9. PubMed ID: 7525544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Refolding and purification of the huGM-CSF(9-127)-IL-6(29-184) fusion protein].
    Sun QM; Liu HY; Dai CB; Ma YB; Sun MS; Xu WM
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):291-4. PubMed ID: 12192859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
    Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
    Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of Recombinant GM-CSF/IL-3 Fusion Protein.
    Zhang Y; Qu XM; Lu JF; Yang SL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(3):235-238. PubMed ID: 12075446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refolding and purification of rhNTA protein by chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved solubilization of recombinant human growth hormone inclusion body produced in Escherichia coli.
    Sonoda H; Sugimura A
    Biosci Biotechnol Biochem; 2008 Oct; 72(10):2675-80. PubMed ID: 18838803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
    Chen Y; Leong SS
    J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Construction of a Pichia pastoris strain efficiently producing recombinant human granulocyte-colony stimulating factor (rhG-CSF) and study of its biological activity on bone marrow cells.
    Pykhtina MB; Romanov VP; Miroshnichenko SM; Beklemishev AB
    Mol Biol Rep; 2020 Jan; 47(1):607-620. PubMed ID: 31713007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient solubilization of inclusion bodies.
    Freydell EJ; Ottens M; Eppink M; van Dedem G; van der Wielen L
    Biotechnol J; 2007 Jun; 2(6):678-84. PubMed ID: 17492713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.
    Ho JG; Middelberg AP
    Biotechnol Bioeng; 2004 Sep; 87(5):584-92. PubMed ID: 15352056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.